Endo Unit Seeks Termination of Drug License Agreement

By Rick Archer (August 22, 2022, 6:23 p.m. EDT) – An affiliate of Endo International on Monday asked a New York bankruptcy judge to stop another pharmaceutical company from voiding asset purchase agreements and of pre-Chapter 11 drug licenses, denying breaches of contracts.

In a heavily redacted complaint, Endo Ventures Ltd. called Nevakar Inc.’s attempt to void a 2018 licensing agreement a “transparent strategic move” to try to avoid the impact of Endo’s Chapter 11 filing on contracts and an act that threatens to undermine the sale of assets and the restructuring plan proposed by Endo.

Irish company Endo International and its subsidiaries filed for Chapter 11 protection last week, saying they needed to tackle…

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
  • Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and more!



Comments are closed.